SCHEMBL30962691

SCHEMBL30962691

COc1nc(Nc2ccc([C@@H]3CCCN(C(=O)OC(C)(C)C)C3)c(C)c2)ncc1C(=O)Nc1c(Cl)cccc1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 2/20 0.42
▸ SRC P12931 3/20 0.39
▸ CCND3 P30281 2/20 0.39
▸ CCNK O75909 2/20 0.39
▸ CCNA2 P20248 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ CDK9 P50750 1/20 0.39
▸ CDK6 Q00534 1/20 0.39
▸ EGFR P00533 2/20 0.39
▸ SIK1 P57059 2/20 0.39
▸ SIK2 Q9H0K1 2/20 0.39
▸ SIK3 Q9Y2K2 2/20 0.39
▸ MAPT P10636 1/20 0.38
▸ MERTK Q12866 1/20 0.38
▸ JAK3 P52333 3/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ TYK2 P29597 1/20 0.38
▸ LCK P06239 1/20 0.37
▸ KDR P35968 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962722 1.00 IGF1R (0.42) IGF1RSRCCCND3CCNKCCNA2
SCHEMBL30962726 1.00 IGF1R (0.42) IGF1RSRCCCND3CCNKCCNA2
SCHEMBL30962660 0.97 IGF1R (0.44) IGF1RSRCCCND3CCNKCCNA2
SCHEMBL30962735 0.97 IGF1R (0.44) IGF1RSRCCCND3CCNKCCNA2
SCHEMBL30962866 0.97 IGF1R (0.44) IGF1RSRCCCND3CCNKCCNA2
SCHEMBL30962711 0.89 SRC (0.43) SRCSIK1SIK2SIK3JAK3
SCHEMBL30962729 0.89 SRC (0.43) SRCSIK1SIK2SIK3JAK3
SCHEMBL30962855 0.89 SRC (0.43) SRCSIK1SIK2SIK3JAK3
SCHEMBL30962615 0.87 WEE1 (0.48) SRCSIK1SIK2SIK3JAK3
SCHEMBL30962635 0.86 WEE1 (0.46) SRCSIK1SIK2SIK3JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
Send feedback